Certificate of Analysis
| Product Name: | Bemnifosbuvir hemisulfate |
| Catalog Number: | M10681 |
| CAS Number: | 2241337-84-6 |
Physical and Chemical Properties
| Formula: | C24H33FN7O7P.1/2(H2O4S) |
| Molecular Weight: | 630.58 |
| Solubility: | DMSO ≥ 130 mg/mL; Water 100 mg/mL |
| Storage: | 4°C, dry, sealed |
| Chemical Structure: |  |
Analytical Data
| QC Standard: | >99% |
| H-NMR: | Consistent with structure |
Product Information
| Description: | Bemnifosbuvir hemisulfate (AT-527) is a guanosine nucleotide prodrug and a potent orally active inhibitor of HCV viral replication. Bemnifosbuvir hemisulfate effectively inhibits SARS-CoV-2 (COVID-19) infection (EC90=0.47 μM). Bemnifosbuvir hemisulfate has whole-genotype antiviral activity. |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |